Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial | CANCER MEDICINE |